A routinely prescribed type 2 diabetes drug called metformin has shown some great potential to cut down mortality rates in select groups of cancer patients, according to a new study. The drug was found to significantly reduce mortality risk associated with certain cancer types, when prescribed to postmenopausal patients with type 2 diabetes and cancer.
Every doctor I’ve ever known has offered me metformin for weight gain side effects even when I didn’t want it. It doesn’t do much for weight gain but at least that’s good news for life expectancy.